21 December 2015 - PHARMAC is seeking feedback on a proposal involving filgrastim and methotrexate prefilled syringes, resulting from a provisional agreement with Novartis New Zealand Ltd. This arose from an Alternative Commercial Proposal in response to consultation on the 2015/16 Invitation to Tender.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2015-12-21-filgrastim-and-methotrexate-pfs/